Neurologic clinical trials - Lemtrada PRO-ACT (observational)

Status:

Open (Study open and enrolling)

CONDITION(S): Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS) - TRIAL: Lemtrada PRO-ACT (observational) - A Prospective, 24-month Observational Study to Evaluate Patient Reported Outcomes and Safety after LEMTRADA ® Treatment in Patients with Relapsing Multiple Sclerosis Switching from a Prior Disease Modifying Therapy.

Trial Type

Observational

Condition

Multiple Sclerosis (MS) Relapsing Multiple Sclerosis (RMS)

Keywords

Relapsing Multiple Sclerosis (RMS) | Multiple Sclerosis (RMS) | Lemtrada